Ventricular sensory neurons in canine dorsal root ganglia: effects of adenosine and substance P

Am J Physiol. 1995 Aug;269(2 Pt 2):R318-24. doi: 10.1152/ajpregu.1995.269.2.R318.

Abstract

Effects elicited by adenosine and substance P on ventricular sensory endings of 14 dorsal root ganglion afferent neurons were studied in situ in anesthetized dogs. Sensory-field application of adenosine (1 microM) increased the activity of these neurons by 179%. Application of a nonspecific adenosine antagonist to epicardial sensory fields suppressed ongoing activity in all 14 neurons by 39%. Application of an A1- or A2-adenosine-receptor antagonist suppressed activity generated by 10 of these neurons by 44 and 59%, respectively. Adenosine applied after A1- or A2-receptor blockade increased activity in 10 neurons by 131 and 145%, respectively, indicating that A1- and A2-receptor effects were not additive. Application of substance P (1 microM) to identified sensory fields increased activity in 12 of these neurons by 169%, whereas application of a substance P-receptor antagonist reduced activity generated by these neurons by 75%. Myocardial ischemia increased activity of nine neurons associated with left ventricular sensory fields by 320%, an effect that was counteracted by the nonspecific adenosine-receptor antagonist. It is concluded that A1- and A2-adenosine receptors, as well as substance P receptors, are present on ventricular epicardial sensory nerve endings of dorsal root ganglion neurons that are tonically active during normal states, becoming further activated during ischemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / pharmacology*
  • Animals
  • Calcium Channel Agonists / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Dogs
  • Female
  • Ganglia, Spinal / cytology
  • Ganglia, Spinal / physiology*
  • Heart / physiology*
  • Heart Ventricles
  • Male
  • Myocardial Ischemia / pathology
  • Myocardial Ischemia / physiopathology
  • Myocardium / cytology
  • Neurons, Afferent / drug effects*
  • Neurons, Afferent / physiology*
  • Pericardium / innervation
  • Receptors, Purinergic P1 / metabolism
  • Substance P / pharmacology*

Substances

  • Calcium Channel Agonists
  • Calcium Channel Blockers
  • Receptors, Purinergic P1
  • Substance P
  • Adenosine